Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(6), P. 689 - 689
Published: May 27, 2024
Public
perception
contrasts
scientific
findings
on
the
depression-related
effects
of
cannabis.
However,
earlier
studies
were
performed
when
cannabis
was
predominantly
illegal,
its
production
mostly
uncontrolled,
and
idea
medical
incipient
only.
We
hypothesized
that
recent
changes
in
attitudes
legislations
may
have
favorably
affected
research.
In
addition,
publication
bias
against
also
decreased.
To
investigate
this
hypothesis,
we
conducted
a
review
research
published
over
last
three
years.
found
156
relevant
articles.
most
cross-sectional
studies,
depression
higher
those
who
consumed
than
did
not.
An
increase
consumption
typically
followed
by
an
depression,
whereas
withdrawal
from
ameliorated
cases.
Although
reduced
none
these
placebo-controlled.
clinical
same
period,
placebo
and,
average
effect
size
larger
investigated
plausibility
antidepressant
reviewing
molecular
pharmacological
studies.
Taken
together,
reviewed
do
not
support
herbal
Horticulture Research,
Journal Year:
2023,
Volume and Issue:
10(9)
Published: July 26, 2023
Is
Cannabis
a
boon
or
bane?
sativa
has
long
been
versatile
crop
for
fiber
extraction
(industrial
hemp),
traditional
Chinese
medicine
(hemp
seeds),
and
recreational
drugs
(marijuana).
faced
global
prohibition
in
the
twentieth
century
because
of
psychoactive
properties
∆9-tetrahydrocannabinol;
however,
recently,
perspective
changed
with
recognition
additional
therapeutic
values,
particularly
pharmacological
potential
cannabidiol.
A
comprehensive
understanding
underlying
mechanism
cannabinoid
biosynthesis
is
necessary
to
cultivate
promote
globally
medicinal
application
resources.
Here,
we
comprehensively
review
historical
usage
Cannabis,
trichome-specific
cannabinoids,
regulatory
network
trichome
development,
synthetic
biology
cannabinoids.
This
provides
valuable
insights
into
efficient
green
production
development
utilization
novel
varieties.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(9), P. 1981 - 1981
Published: April 25, 2024
It
has
been
several
years
since
highly
purified
cannabidiol
(CBD)
was
registered
as
a
medication
that
can
be
used
in
children
of
at
least
2
age
to
treat
different
types
seizures
related
Lennox–Gastaut
syndrome
(LGS),
Dravet
(DS),
and
more
recently
tuberous
sclerosis
complex
(TSC).
During
this
time,
39
randomized
clinical
trials
(RCTs)
13
meta-analyses
on
the
efficacy
safety
CBD
treatment
have
published.
Each
had
its
own
criteria
for
RCTs’
inclusion
and,
therefore,
slightly
interpretations
analyzed
data.
them
contributed
way
understanding
pharmacology,
mechanisms
therapeutic
action,
development
adverse
reactions,
drug–drug
interactions.
Hence,
it
seemed
reasonable
gather
most
relevant
data
one
article
present
all
current
knowledge
use
epilepsy.
The
results
presented
herein
confirmed
effectiveness
adolescents
with
DREs.
In
adults,
reliable
conclusions
cannot
drawn
due
insufficient
Expert Opinion on Therapeutic Targets,
Journal Year:
2024,
Volume and Issue:
28(9), P. 739 - 755
Published: Sept. 1, 2024
This
review
highlights
the
critical
role
of
endocannabinoid
system
(ECS)
in
regulating
neuropathic
pain
and
explores
therapeutic
potential
cannabinoids.
Understanding
mechanisms
ECS,
including
its
receptors,
endogenous
ligands,
enzymatic
routes,
can
lead
to
innovative
treatments
for
chronic
pain,
offering
more
effective
therapies
conditions.
bridges
gap
between
preclinical
studies
clinical
applications
by
emphasizing
ECS
modulation
better
management
outcomes.
Basic & Clinical Pharmacology & Toxicology,
Journal Year:
2024,
Volume and Issue:
135(3), P. 225 - 236
Published: July 22, 2024
Abstract
Neurolipids
comprise
a
diverse
class
of
bioactive
lipids
that
include
molecules
capable
activating
G
protein‐coupled
receptors,
thereby
inducing
systemic
effects
contribute
to
the
maintenance
homeostasis.
Dementia,
non‐specific
brain
disorder
characterized
by
common
set
signs
and
symptoms,
usually
arises
subsequent
injuries
or
diseases
is
often
associated
with
aging
process.
Individuals
affected
dementia
suffer
from
disruption
several
neurotransmitter
neuromodulatory
systems,
among
which
neurolipids
play
an
important
role,
including
endocannabinoid,
lysophosphatidic
acid
sphingosine
1‐phosphate
systems.
In
this
review,
we
present
overview
most
recent
pertinent
findings
regarding
involvement
these
neurolipidic
systems
in
dementia,
data
wide
range
both
vitro
vivo
experiments
as
well
clinical
trials.
FEBS Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 22, 2025
Duchenne
muscular
dystrophy
is
a
severe
neuromuscular
wasting
disease
that
caused
by
primary
defect
in
dystrophin
protein
and
involves
organism‐wide
comorbidities
such
as
cardiomyopathy,
metabolic
mitochondrial
dysfunction,
nonprogressive
cognitive
impairments.
Physiological
stress
exposure
the
mdx
mouse
model
of
results
phenotypic
abnormalities
include
locomotor
inactivity,
hypotension,
increased
morbidity.
Severe
lethal
susceptibility
mice
corresponds
to
dysfunction
several
coordinated
pathways
within
dystrophin‐deficient
skeletal
muscle,
well
prolonged
elevation
plasma
corticosterone
levels
extends
beyond
wild‐type
(WT)
response.
Here,
we
performed
targeted
mass
spectrometry‐based
metabolomics
screen
focused
on
biological
healthy
exposed
mild
scruff
stress.
One‐third
stress‐relevant
metabolites
interrogated
displayed
significant
or
depletion
after
were
restored
WT
muscle‐specific
expression.
The
altered
are
associated
with
regulation
hypothalamic–pituitary–adrenal
axis,
tone,
neurocognitive
function,
redox
metabolism,
cellular
bioenergetics,
catabolism.
Our
data
suggest
triggers
an
exaggerated,
multi‐system
response
mice.
Annals of Plastic Surgery,
Journal Year:
2025,
Volume and Issue:
94(4S), P. S188 - S193
Published: April 1, 2025
Introduction
Given
recent
efforts
to
legalize
and
decriminalize
recreational
marijuana,
its
use
has
become
increasingly
common
in
the
plastic
surgery
patient
population.
Although
cannabis
generally
been
considered
lower
risk
than
of
other
substances,
studies
have
suggested
it
may
be
associated
with
an
increased
surgical
complication
rate.
The
aims
our
study
were
(1)
characterize
extent
(2)
determine
clinical
effects
cohort
patients
undergoing
autologous
breast
reconstruction
using
deep
inferior
epigastric
perforator
(DIEP)
flaps.
Methods
A
retrospective
was
conducted
adult
who
underwent
DIEP
flaps
between
January
2015
December
2023
by
5
surgeons
at
institution.
Patients
divided
into
2
groups
users
nonusers.
Univariate
multivariable
analyses
performed
assess
outcomes
groups.
Results
total
87
(12.1%)
632
nonusers
included.
5-fold
increase
proportion
from
found.
Cannabis
significantly
younger
(47.5
vs
51.7,
P
<
0.001)
had
a
higher
body
mass
index
(30.5
28.9,
=
0.012).
Postoperatively,
readmission
rate
(8.0%
3.2%,
0.035)
longer
time
last
abdominal
drain
removal
(21
17
days,
0.001).
After
controlling
for
confounders,
logistic
regression
revealed
as
significant
factor
postoperative
general
hematoma
(OR:
3.078,
confidence
interval
[95%
CI]:
1.265–7.491,
0.013),
3.098,
95%
CI:
1.197–8.020,
0.020),
2.865,
1.098–7.475,
0.031).
Conclusion
To
knowledge,
this
is
largest
examining
receiving
reconstruction.
Our
findings
suggest
that
require
greater
care
attention.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(21), P. 15777 - 15777
Published: Oct. 30, 2023
Endocannabinoids
were
implicated
in
a
variety
of
pathological
conditions
including
anxiety
and
are
considered
promising
new
targets
for
anxiolytic
drug
development.
The
optimism
concerning
the
potentials
this
system
anxiolysis
is
probably
justified.
However,
complexity
mechanisms
affected
by
endocannabinoids,
discrepant
findings
obtained
with
various
experimental
approaches
makes
interpretation
research
results
difficult.
Here,
we
review
anxiety-related
effects
three
main
interventions
used
to
study
endocannabinoid
system:
pharmacological
agents
active
at
endocannabinoid-binding
sites
present
on
both
cell
membrane
cytoplasm,
genetic
manipulations
targeting
cannabinoid
receptors,
function-enhancers
represented
inhibitors
degradation
transport.
Binding-site
ligands
provide
inconsistent
because
they
activate
multitude
concomitantly.
More
robust
particularly
function
enhancers,
which
heighten
ongoing
activation
rather
than
affecting
all
indiscriminately.
enhancement
activity
appears
ameliorate
stress-induced
without
consistent
general.
Limited
evidence
suggests
that
effect
achieved
promoting
coping
styles
critical
situations.
These
suggest
functional
signaling
development
target
stress-related
disorders.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(4), P. 2271 - 2271
Published: Feb. 14, 2024
Endocannabinoid
anandamide
(AEA)
and
paracannabinoid
lysophosphatidylinositol
(LPI)
play
a
significant
role
in
cancer
cell
proliferation
regulation.
While
inhibits
the
of
cells,
LPI
is
known
as
stimulant.
Despite
endocannabinoid
receptor
crosstalk
simultaneous
presence
microenvironment
both
molecules,
their
combined
activity
has
never
been
studied.
We
evaluated
effect
on
AEA
six
human
breast
lines
different
carcinogenicity
(MCF-10A,
MCF-7,
BT-474,
BT-20,
SK-BR-3,
MDA-MB-231)
using
resazurin
LDH
tests
after
72
h
incubation.
exerted
anti-proliferative
cytotoxic
with
EC50
range
from
31
to
80
µM.
did
not
significantly
affect
viability.
Depending
line,
response
LPI–AEA
combination
varied
decrease
cytotoxicity
an
increase
it.
Based
inhibitor
analysis
panel,
we
showed
that
for
former
effect,
active
GPR18
was
required
latter,
CB2
receptor.
The
data
obtained
first
time
are
important
understanding
manner
by
which
ligands
acting
simultaneously
can
modulate
growth
at
stages.